Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota.
Am J Physiol Cell Physiol. 2022 Jul 1;323(1):C116-C124. doi: 10.1152/ajpcell.00468.2021. Epub 2022 May 11.
Retinal pigmented epithelial (RPE) cells play an important role in retinal fibrotic diseases such as proliferative vitreoretinopathy (PVR). The purpose of this study was to elucidate the involvement of dopamine receptor signaling in regulating the fibrotic activation of RPE cells. Dopamine receptor expression, the effect of dopamine on fibrotic activity, and dopamine production were measured in the human RPE cell line ARPE-19. The fibrotic activation of RPE cells was evaluated in response to treatments with selective dopamine receptor agonists and antagonists by measuring gene expression, migration, proliferation, and fibronectin deposition. and are the dominant dopaminergic receptors expressed in ARPE-19 cells and TGF-β stimulation enhances the autocrine release of dopamine, which we show further exasperates fibrotic activation. Finally, treatment with D2 dopamine receptor antagonists or D5 dopamine receptor agonists inhibits profibrotic gene expression, migration, proliferation, and fibronectin deposition and thus may serve as effective mechanisms for treating retinal fibrosis including PVR.
视网膜色素上皮 (RPE) 细胞在增殖性玻璃体视网膜病变 (PVR) 等视网膜纤维化疾病中发挥重要作用。本研究旨在阐明多巴胺受体信号在调节 RPE 细胞纤维化激活中的作用。在人 RPE 细胞系 ARPE-19 中测量多巴胺受体表达、多巴胺对纤维化活性的影响和多巴胺的产生。通过测量基因表达、迁移、增殖和纤维连接蛋白沉积,评估 RPE 细胞对选择性多巴胺受体激动剂和拮抗剂的纤维化激活反应。 和 是在 ARPE-19 细胞中表达的主要多巴胺能受体,TGF-β 刺激增强多巴胺的自分泌释放,我们进一步表明这加剧了纤维化激活。最后,D2 多巴胺受体拮抗剂或 D5 多巴胺受体激动剂的治疗抑制了促纤维化基因表达、迁移、增殖和纤维连接蛋白沉积,因此可能成为治疗包括 PVR 在内的视网膜纤维化的有效机制。